Cargando...

A Modifying Autoantigen in Graves’ Disease

The TSH receptor (TSHR) is the major autoantigen in Graves’ disease (GD). Bioinformatic analyses predict the existence of several human TSHR isoforms from alternative splicing, which can lead to the coexpression of multiple receptor forms. The most abundant of these is TSHRv1.3. In silico modeling o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Endocrinology
Main Authors: Latif, Rauf, Mezei, Mihaly, Morshed, Syed A, Ma, Risheng, Ehrlich, Rachel, Davies, Terry F
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6455603/
https://ncbi.nlm.nih.gov/pubmed/30822352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2018-01048
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!